Поисковый запрос: (<.>S=ВОРИКОНАЗОЛ<.>) |
Общее количество найденных документов : 214
Показаны документы с 1 по 20
|
|
1.
| A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections // Mycoses, 2011. Vol. 54, N 3.-С.234-242
|
2.
| A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections // Mycoses, 2011. Vol. 54, N 3.-С.234-242
|
3.
| Activities and ultrastructural effects of antifungal combinations against simulated Candida endocardial vegetations // Antimicrob. Agents and Chemother., 2008. Vol. 52, N 7.-С.2367-2376
|
4.
| Activities of antifungal agents against yeasts and filamentous fungi: Assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing // Antimicrob. Agents and Chemother., 2008. Vol. 52, N 10.-С.3637-3641
|
5.
| Adverse effects of voriconazole: Analysis of the French pharmacovigilance database // Ann. Pharmacother., 2007. Vol. 41, N 5.-С.755-763
|
6.
| Kappe R. Antifungal activity of the new azole UK-109, 496 (voriconazole) // Mycoses, 1999. Vol. 42, Suppl. 2.-С.83-86
|
7.
| Kappe R. Antifungal activity of the new azole UK-109, 496 (voriconazole) // Mycoses, 1999. Vol. 42, Suppl. 2.-С.83-86
|
8.
| Bioavailability and population pharmacokinetics of voriconazole in lung transplant recipients // Antimicrob. Agents and Chemother., 2010. Vol. 54, N 10.-С.4424-4431
|
9.
| Bronchopulmonary disposition of intravenous voriconazole and anidulafungin given in combination to healthy adults // Antimicrob. Agents and Chemother., 2009. Vol. 53, N 12.-С.5102-5107
|
10.
| Bronchopulmonary disposition of intravenous voriconazole and anidulafungin given in combination to healthy adults // Antimicrob. Agents and Chemother., 2009. Vol. 53, N 12.-С.5102-5107
|
11.
| Bernhardt Changes in Candida albicans colonization and morphology under influence of voriconazole // Mycoses, 2003. Vol. 46, N 9-10.-С.370-374
|
12.
| Howard Clinical application of voriconazole concentrations in the treatment of invasive aspergillosis // Ann. Pharmacother., 2008. Vol. 42, N 12.-С.1859-1864
|
13.
| Howard Clinical application of voriconazole concentrations in the treatment of invasive aspergillosis // Ann. Pharmacother., 2008. Vol. 42, N 12.-С.1859-1864
|
14.
| Clinical isolates of Aspergillus species remain fully susceptible to voriconazole in the post-voriconazole era // Antimicrob. Agents and Chemother., 2008. Vol. 52, N 9.-С.3444-3446
|
15.
| Kauffman Carol A. Colorimetric method for susceptibility testing of voriconazole and other triazoles against Candida species // Mycoses, 1999. Vol. 42, N 9-10.-С.539-542
|
16.
| Kauffman Carol A. Colorimetric method for susceptibility testing of voriconazole and other triazoles against Candida species // Mycoses, 1999. Vol. 42, N 9-10.-С.539-542
|
17.
| Combination efficacy of voriconazole and amphotericin B in the experimental disease in immunodeficient mice caused by fluconazole-resistant Cryptococcus neoformans // Mycopathologia, 2011. Vol. 171, N 4.-С.261-266
|
18.
| Combination efficacy of voriconazole and amphotericin B in the experimental disease in immunodeficient mice caused by fluconazole-resistant Cryptococcus neoformans // Mycopathologia, 2011. Vol. 171, N 4.-С.261-266
|
19.
| Combination efficacy of voriconazole and amphotericin B in the experimental disease in immunodeficient mice caused by fluconazole-resistant Cryptococcus neoformans // Mycopathologia, 2011. Vol. 171, N 4.-С.261-266
|
20.
| Combination therapy in treatment of experimental pulmonary aspergillosis: In vitro and in vivo correlations of the concentration - and dose-dependent interactions between anidulafungin and voriconazole by bliss independence drug interaction analysis // Antimicrob. Agents and Chemother., 2009. Vol. 53, N 6.-С.2382-2391
|
&uf('+1W2226#',v2226), ?>
|
|